Cognito Therapeutics Secures Series C Funding to Advance Noninvasive Neuromodulation Device for Alzheimer’s Treatment and Market Preparation
Cognito Therapeutics, a clinical-stage medical technology company, has successfully closed a Series C financing round aimed at accelerating the commercialization…
